Acumapimod
An orally active, potent p38 MAPK inhibitor that potently inhibits ex vivo LPS‐induced TNFα secretion with an IC50 of 44 ng/mL (115 nM) ; inhibits LPS‐stimulated TNFα release in the human whole blood assay with IC50 of 24 nM; shows antiinflammatory activity for treatment of acute as opposed to chronic inflammation disorders.COPD Phase 1 Clinical.
Product Specifications
CAS Number
836683-15-9
Product Name Alternative
BCT-197
Purity
>98% (HPLC)
Solubility
DMSO: 10 mM
Smiles
O=C (NC1CC1) C2=CC=C (C) C (N3N=CC (C (C4=CC=CC (C#N) =C4) =O) =C3N) =C2
Molecular Formula
C22H19N5O2
Molecular Weight
385.4185
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
Benzamide, 3-[5-amino-4- (3-cyanobenzoyl) -1H-pyrazol-1-yl]-N-cyclopropyl-4-methyl-
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
038518-HRP 200 µL
MN1, ID (MN1, Probable tumor suppressor protein MN1) (Azide free) (HRP) discontinued
Sign In for Pricing
View Details